Syndax Pharmaceuticals (SNDX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Syndax Pharmaceuticals (SNDX) over the last 11 years, with Q3 2025 value amounting to -$1.5 million.
- Syndax Pharmaceuticals' Other Gross PP&E Adjustments fell 698.18% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year decrease of 698.18%. This contributed to the annual value of -$2.0 million for FY2024, which is 2104.85% up from last year.
- As of Q3 2025, Syndax Pharmaceuticals' Other Gross PP&E Adjustments stood at -$1.5 million, which was down 698.18% from -$1.6 million recorded in Q2 2025.
- Over the past 5 years, Syndax Pharmaceuticals' Other Gross PP&E Adjustments peaked at -$732000.0 during Q2 2021, and registered a low of -$3.3 million during Q3 2023.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$1.9 million (2022), whereas its average is -$1.9 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first crashed by 118333.33% in 2021, then soared by 5857.19% in 2024.
- Quarter analysis of 5 years shows Syndax Pharmaceuticals' Other Gross PP&E Adjustments stood at -$924000.0 in 2021, then tumbled by 113.42% to -$2.0 million in 2022, then decreased by 27.69% to -$2.5 million in 2023, then increased by 21.05% to -$2.0 million in 2024, then increased by 26.01% to -$1.5 million in 2025.
- Its last three reported values are -$1.5 million in Q3 2025, -$1.6 million for Q2 2025, and -$2.9 million during Q1 2025.